Received Jul 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Shingles outbreak.; Swelling; Arm redness; This non-serious case was reported by a nurse via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On 30-JUN-2025, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles outbreak.), swelling (Verbatim: Swelling) and erythema of extremities (Verbatim: Arm redness). The outcome of the shingles, swelling and erythema of extremities were unknown. It was unknown if the reporter considered the shingles, swelling and erythema of extremities to be related to Shingrix. It was unknown if the company considered the shingles, swelling and erythema of extremities to be related to Shingrix. Additional Information: GSK Receipt Date: 08-JUL-2025 The nurse practitioner called to inform that a patient with some mild shingles symptoms and wanted to beat the shingles symptoms and got the 1st dose of Shingrix on 30th June 2025. The reporter mentioned that after getting Shingrix, patient had swelling and arm redness and shingles symptoms. No further details provided. This case US2025086143 was reported by same reporter.; Sender's Comments: US-GSK-US2025086143:Same reporter different patient